×

img Acces sibility Controls

Technologies Banner

All Technologies

Live Attenuated SARS – CoV-2 vaccine

Implementing Organization

Griffith University, Australia

About

A Live Attenuated Severe Acute Respiratory Syndrome Coronavirus Is Immunogenic and Efficacious in Golden Syrian Hamsters. The technology looks promising for developing a vaccine for prophylactic, active, single dose immunization against coronavirus in humans, with an enhanced safety profile. The vaccine is expected to provide long-lasting protection with a single dose administration with an anticipated safety profile similar to other licensed vaccines for active immunization.
Funding Organization
Funding Organization

Quick Information
Focus Area
Development of vaccine for COVID-19
Status
1
Output
No. of Research Paper
00
Technologies (If Any)
00
No. of PhD Produced
N/A
Startup (If Any)
00
No. of Patents
Filed :00
Grant :00
arrowtop